Technological advancements such as Sky Medical Technology‘s wearable geko™ device mark a new era in the treatment of Venous Leg … continue reading “Venous Leg Ulcers; Economics and MedTech’s Answers”
Companies
FDA Clears First Spine Device for Ligament Augmentation
Medtronic plc, has received U.S. FDA 510(k) clearance and Breakthrough Device designation for its novel LigaPASS™ 2.0 Ligament Augmentation System. … continue reading “FDA Clears First Spine Device for Ligament Augmentation”
Tibial Neuromodulation for OAB: First Patient Implants
Medtronic plc says the first patient implants in the TITAN 2 pivotal study will evaluate the safety and efficacy of … continue reading “Tibial Neuromodulation for OAB: First Patient Implants”
ABHI Launches US Accelerator 2022 Programme
Forty UK HealthTech Innovators Seek Support Stateside The UK’s health technology industry body, the Association of British HealthTech Industries (ABHI) … continue reading “ABHI Launches US Accelerator 2022 Programme”
Record Demand Sees ABHI US Accelerator Expand Offer
The Association of British HealthTech Industries (ABHI) US Accelerator has received a record number of applications for its 2022 cohort. … continue reading “Record Demand Sees ABHI US Accelerator Expand Offer”
$17m New Finance for 4D Cardiac Imaging Tech
Imagine four-dimensional (4D) imagery of the beating heart, viewed live, in 360°. Now add real-time tissue analysis to the same … continue reading “$17m New Finance for 4D Cardiac Imaging Tech”
Medtronic Breaks Ground on New Innovation Center
Medtronic plc has announced the groundbreaking of a new campus in Lafayette, Colorado. The new campus will unite 1000 employees from … continue reading “Medtronic Breaks Ground on New Innovation Center”
Pain Relief Boost with Spinal Cord Stimulator Approval
Pain relief using implantable neurostimulation has come on a lot in recent times. For evidence, try searching our pages. Now … continue reading “Pain Relief Boost with Spinal Cord Stimulator Approval”
U.S. FDA Approves Pipeline™ Flex Embolization Device with Shield Technology™
Medtronic plc has received U.S. FDA approval for Pipeline™ Flex Embolization Device with Shield Technology™. Background An estimated 500,000 people throughout the … continue reading “U.S. FDA Approves Pipeline™ Flex Embolization Device with Shield Technology™”
FDA Approves Expanded Labeling of Medtronic MRI Leads
Medtronic plc says it has received approval from the U.S. FDA for expanded MRI labeling of its InterStim™ II and InterStim™ … continue reading “FDA Approves Expanded Labeling of Medtronic MRI Leads”
FDA Clearances Enhance Mazor™ Robotic Guidance System
The U.S. FDA has cleared the use of navigated interbody and Midas Rex™ high speed drills with the Mazor™ Robotic Guidance System earlier than originally anticipated
FDA OKs ReCor Paradise™ Ultrasound Renal Denervation
ReCor Medical’s Paradise™ Ultrasound Renal Denervation System has received Breakthrough Device Designation from the U.S. FDA for the treatment of patients with uncontrolled hypertension who are inadequately responsive to anti-hypertensive medications.
Carpediem™ First Cardio-Renal Pediatric Dialysis Launch
Medtronic plc has announced the U.S. commercial launch of the Carpediem™ Cardio-Renal Pediatric Dialysis Emergency Machine, the first and only … continue reading “Carpediem™ First Cardio-Renal Pediatric Dialysis Launch”
U.S. Launch for Boston Scientific SpaceOAR Vue™ Hydrogel
Next-generation Hydrogel spacer offers enhanced visibility via CT Scan to optimize treatment planning for patients undergoing radiation for prostate cancer. … continue reading “U.S. Launch for Boston Scientific SpaceOAR Vue™ Hydrogel”
Medtronic’s ENT Portfolio Grows with FDA Clearance of NIM Vital and Acquisition of Ai Biomed
Medtronic plc, has received U.S. FDA 510(k) clearance of the NIM Vital™ nerve monitoring system, which enables physicians to identify, … continue reading “Medtronic’s ENT Portfolio Grows with FDA Clearance of NIM Vital and Acquisition of Ai Biomed”
Medtronic DTM™ Spinal Cord Stimulation Therapy Outperforms Conventional SCS Therapy for Back Pain Relief at 12 Months
Statistically significant 12-month results from a large, multicenter randomized controlled trial confirm 84% Back Pain Responder Rate and 69% Profound … continue reading “Medtronic DTM™ Spinal Cord Stimulation Therapy Outperforms Conventional SCS Therapy for Back Pain Relief at 12 Months”